1. Home
  2. OVID vs XPL Comparison

OVID vs XPL Comparison

Compare OVID & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • XPL
  • Stock Information
  • Founded
  • OVID 2014
  • XPL 1984
  • Country
  • OVID United States
  • XPL United States
  • Employees
  • OVID N/A
  • XPL N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • XPL Precious Metals
  • Sector
  • OVID Health Care
  • XPL Basic Materials
  • Exchange
  • OVID Nasdaq
  • XPL Nasdaq
  • Market Cap
  • OVID 54.1M
  • XPL 49.4M
  • IPO Year
  • OVID 2017
  • XPL N/A
  • Fundamental
  • Price
  • OVID $0.74
  • XPL $0.65
  • Analyst Decision
  • OVID Strong Buy
  • XPL Strong Buy
  • Analyst Count
  • OVID 5
  • XPL 2
  • Target Price
  • OVID $4.04
  • XPL $1.60
  • AVG Volume (30 Days)
  • OVID 384.9K
  • XPL 43.4K
  • Earning Date
  • OVID 03-07-2025
  • XPL 11-05-2024
  • Dividend Yield
  • OVID N/A
  • XPL N/A
  • EPS Growth
  • OVID N/A
  • XPL N/A
  • EPS
  • OVID N/A
  • XPL N/A
  • Revenue
  • OVID $631,695.00
  • XPL N/A
  • Revenue This Year
  • OVID $71.38
  • XPL N/A
  • Revenue Next Year
  • OVID $5,144.81
  • XPL N/A
  • P/E Ratio
  • OVID N/A
  • XPL N/A
  • Revenue Growth
  • OVID 113.21
  • XPL N/A
  • 52 Week Low
  • OVID $0.68
  • XPL $0.43
  • 52 Week High
  • OVID $4.10
  • XPL $0.98
  • Technical
  • Relative Strength Index (RSI)
  • OVID 25.31
  • XPL 58.24
  • Support Level
  • OVID $0.75
  • XPL $0.59
  • Resistance Level
  • OVID $1.01
  • XPL $0.63
  • Average True Range (ATR)
  • OVID 0.07
  • XPL 0.03
  • MACD
  • OVID -0.02
  • XPL 0.01
  • Stochastic Oscillator
  • OVID 6.25
  • XPL 78.00

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About XPL Solitario Resources Corp.

Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.

Share on Social Networks: